Filing Details
- Accession Number:
- 0001209191-16-135776
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-08-08 10:16:03
- Reporting Period:
- 2016-08-04
- Filing Date:
- 2016-08-08
- Accepted Time:
- 2016-08-08 10:16:03
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
742112 | Invacare Corp | IVC | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 952680965 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1236982 | Martin C Harris | One Invacare Way Elyria OH 44035 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares | Disposition | 2016-08-04 | 475 | $11.49 | 29,152 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Shares | Stock Option (Right to Buy) | $0.00 | 12,569 | 12,569 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
12,569 | 12,569 | Direct |
Footnotes
- Includes an aggregate of 9,932 restricted stock units issued pursuant to the Invacare Corporation 2013 Equity Compensation Plan.
- No transaction is being reported on this line. Reported on a previously filed Form 3, Form 4, or Form 5.
- The reporting person holds previously reported options to buy 12,569 Common Shares (with tandem tax withholding rights) under the Invacare Corporation 2003 Performance Plan, granted in reliance upon the exemption provided by Rule 16b-3. All options were granted between August 22, 2007 and August 20, 2008, at exercise prices between $23.71 to $25.79 per share, will expire between August 22, 2017 and August 20, 2018, and became exercisable between September 30, 2008 and September 30, 2012.
- The current balance reflects the expiration of 4,000 options on March 8, 2016.